SpotCheck Teledermoscopy Tool Can Be Highly Accurate in Diagnosing Melanoma

November 16, 2024

ASDS 2024: Results From DecisionDx-Melanoma and DecisionDx-SCC Help Guide Skin Cancer Treatment Decisions

October 21, 2024

New AI Model Trumps 7PCL and Williams Score for Spotting Skin Cancers

October 17, 2024

Castle Biosciences, Inc.’s DecisionDx-SCC Better IDs High-risk Immune-suppressed SCC Patients Who Need ART

September 30, 2024

“Practice-changing” Results: Long-term Advanced Melanoma Survival Dramatically Improves on Immunotherapy

September 15, 2024

Study Examines Sex-specific Trends in Melanoma

September 15, 2024

Image-Guided SRT Boasts Consistent High Freedom From Recurrence of Nonmelanoma Skin Cancer Regardless of Age or Sex

September 13, 2024

Castle’s DecisionDx-Melanoma Test Can Identify Melanoma Patients with Low Risk of Sentinel Lymph Node Positivity Who Can Forego Biopsy

September 11, 2024

Turning the Tables on Skin Cancer: Melanoma Risk, Mortality Declining Among Young Adults in Sweden

September 9, 2024

Is Melanoma More Lethal in Men Because of Age-related Changes in Fibroblasts?

September 6, 2024

Precancerous MBL Linked to Heightened Melanoma Risk

September 6, 2024

Castle’s DecisionDx-SCC Test Predicts Likelihood of Benefit From Adjuvant Radiation Therapy in SCC

September 5, 2024